Meridian Bioscience reported $42.75M in Cost of Sales for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Abbott ABT:US $ 4987M 267M
Accelerate Diagnostics AXDX:US 2.16M 5K
Atrion ATRI:US 22.92M 2.15M
Becton, Dickinson and BDX:US $ 2706M 134M
Bio Rad Laboratories BIO:US $ 296.5M 35.37M
Cerus CERS:US $ 18.08M 1.4M
Meridian Bioscience VIVO:US $ 42.75M 3.57M
Myriad Genetics MYGN:US $ 48M 2.2M
Orasure Technologies OSUR:US $ 43.44M 7M
Quidel QDEL:US $ 262.3M 114.78M
Sientra SIEN:US $ 8.55M 1.77M
Staar Surgical STAA:US $ 13.94M 0.07M
Thermo Fisher Scientific TMO:US $ 6354M 906M
Trinity Biotech TRIB:US $ 11.51M 0.78M
Utah Medical Products UTMD:US 4.5M 482K